Methylnaltrexone

Pharmaceutical standards - Methylnaltrexone is approved for the treatment of opioid-induced constipation (OIC). It is generally only to be used when ordinary laxatives have failed. Reference standards of Methylnaltrexone API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => Methylnaltrexone
    [catalogue_number] => PA 13 2490000
    [category_ids] => ,75,76,78,70,82,
    [chemical_name] => 
    [weight] => 356.44
    [form] => C21H26NO4+
    [cas] => 916055-93-1
    [pslug] => 916055-93-1-methylnaltrexone-api-pa132490000
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA 13 2490000
PA 13 2490000

Methylnaltrexone


  • Catalogue No.:PA 13 2490000

  • CAS :

    916055-93-1

  • Molecular Formula : C21H26NO4+

  • Molecular Weight : 356.44

pharmaffiliates